Activation of programmed cell death (apoptosis) by adriamycin in human neoplastic cells.
We have studied the occurrence of the apoptosis phenomenon in the action of adriamycin (ADR) on human melanoma cells sensitive (ME18) and resistant (ME18/R) to ADR. The study has shown that the intensity of apoptotic morphological changes noted in melanoma cells depended on the duration of the ADR treatment. We have not observed any positive correlation between the induction of apoptosis and sensitivity to ADR. We have used a fluorescence microscope and flow cytometer to evaluate apoptotic events in cells treated with ADR.
Gruber
B M
BM
Department of Vitamin Drugs, Drug Institute, 30/34 Chelmska Str., 00-725, Warsaw, Poland.
Anuszewska
E L
EL
Skierski
J S
JS
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D004317:Doxorubicin / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D005434:Flow Cytometry; D005456:Fluorescent Dyes; D006801:Humans; D007211:Indoles; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology*; D008856:Microscopy, Fluorescence; D012235:Rhodamines; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D005456:Fluorescent Dyes; D007211:Indoles; D012235:Rhodamines; C007293:DAPI; D004317:Doxorubicin